Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brower

Showing results (231-240 of 1,954) with videos related to

Pageof 196
Sort By:
The Lancet. Oncology|June 21, 2016
Anti-PD-L1 inhibitor durvalumab in bladder cancerVicki Brower
Journal of the National Cancer Institute|December 24, 2014
New approaches tackle rising pancreatic cancer ratesVicki Brower
The Lancet. Oncology|December 30, 2015
Afatinib and chemotherapy in non-small-cell lung cancerVicki Brower
The Lancet. Oncology|April 13, 2016
Crizotinib improves intracranial metastasis controlVicki Brower
EMBO Reports|March 14, 2003
Biotechnology to fight bioterrorism. While the fight against terrorism is helping to revitalize the biotech market, academic scientists are starting to worry about limitations on researchVicki Brower
Journal of the National Cancer Institute|March 6, 2003
Biotech industry tries to recover from 2-year lullVicki Brower
EMBO Reports|May 3, 2003
Looking for the trigger. The Environmental Genome Project to uncover the interactions of genes and the environment in diseaseVicki Brower
The Lancet. Oncology|February 8, 2003
Normal and neoplastic prostate cells have EPO receptorsVicki Brower
EMBO Reports|July 9, 2002
Fighting fat. New drugs against obesity in the pipelineVicki Brower
The Lancet. Neurology|July 10, 2003
Fighting fire with fire in autoimmune diseaseVicki Brower
Pageof 196

Showing results (231-240 of 1,954) with videos related to

Sort By:
Pageof 196
The Lancet. Oncology|June 21, 2016
Anti-PD-L1 inhibitor durvalumab in bladder cancerVicki Brower
Journal of the National Cancer Institute|December 24, 2014
New approaches tackle rising pancreatic cancer ratesVicki Brower
The Lancet. Oncology|December 30, 2015
Afatinib and chemotherapy in non-small-cell lung cancerVicki Brower
The Lancet. Oncology|April 13, 2016
Crizotinib improves intracranial metastasis controlVicki Brower
EMBO Reports|March 14, 2003
Biotechnology to fight bioterrorism. While the fight against terrorism is helping to revitalize the biotech market, academic scientists are starting to worry about limitations on researchVicki Brower
Journal of the National Cancer Institute|March 6, 2003
Biotech industry tries to recover from 2-year lullVicki Brower
EMBO Reports|May 3, 2003
Looking for the trigger. The Environmental Genome Project to uncover the interactions of genes and the environment in diseaseVicki Brower
The Lancet. Oncology|February 8, 2003
Normal and neoplastic prostate cells have EPO receptorsVicki Brower
EMBO Reports|July 9, 2002
Fighting fat. New drugs against obesity in the pipelineVicki Brower
The Lancet. Neurology|July 10, 2003
Fighting fire with fire in autoimmune diseaseVicki Brower
Pageof 196